Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[nep2134]

Oct 2014? You know how long ago that was in medical research? Things are happening so fast the date becomes an important part in reading medical research.

That isn't to mean that the older research doesn't still have value. Maybe there is data there that others missed. Or at the least you can see what others have considered and now has been discarded.

If nilvadipine showed any kind of positive results, would we be sitting here going on 10 months after the trials ended still waiting on the report? If it's a dud then there is no hurry to get the report out. What if the results show that nilvadipine did reduce beta amyloid, the tau "tangles", and reduce calcium but made no difference?

What if they are going to the trouble of peer review so then they can argue that beta amyloid is a dead end and has been a waste of time?

All this really though is immaterial to anatabine. There is so much more to anatabine then alzheimer's.